Y Jung1, J L Whitwell2, J R Duffy1, E A Strand1, M M Machulda3, M L Senjem4, C R Jack2, V J Lowe5, K A Josephs1. 1. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 2. Department of Radiology, Mayo Clinic, Rochester, MN, USA. 3. Department of Psychiatry and Psychology (Neuropsychology), Mayo Clinic, Rochester, MN, USA. 4. Department of Information Technology, Mayo Clinic, Rochester, MN, USA. 5. Department of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND AND PURPOSE: A subset of patients with Alzheimer's disease (AD) present with early and prominent language impairment (aphasic AD). Our previous study demonstrated an association between global β-amyloid burden measured on [(11)C] Pittsburgh compound B (PiB) positron emission tomography and general cognitive impairment, but not with aphasia, in such subjects. As a follow-up, whether there is any association between regional β-amyloid burden, atrophy on magnetic resonance imaging (MRI) and global cognitive impairment, aphasia or other cognitive and functional impairment in aphasic AD is assessed. METHODS: Forty-four aphasic AD subjects who underwent PiB scanning and volumetric MRI and were determined to be positive for β-amyloid deposition were analyzed. All had completed detailed neurological, neuropsychological and language batteries. Spearman's rank-order correlation was utilized to assess for associations. RESULTS: Greater visuospatial impairment was associated with increased β-amyloid burden in the primary visual cortex (P = 0.001). Although there were many trends for associations between neurocognitive and language deficits and regional β-amyloid burden, there were no strong associations that survived correction for multiple comparisons. However, neurocognitive and language impairment in these subjects strongly correlated with the degree of left lateral temporal and inferior parietal atrophy (P < 0.004). CONCLUSIONS: The findings from this study suggest a close relation between the severity of regional atrophy and cognitive and language impairment, but argue against a strong association between regional β-amyloid burden and such deficits in aphasic AD subjects. Hence, other pathological factors may be driving the previously identified association between global β-amyloid deposition and general cognitive impairment in aphasic AD.
BACKGROUND AND PURPOSE: A subset of patients with Alzheimer's disease (AD) present with early and prominent language impairment (aphasic AD). Our previous study demonstrated an association between global β-amyloid burden measured on [(11)C] Pittsburgh compound B (PiB) positron emission tomography and general cognitive impairment, but not with aphasia, in such subjects. As a follow-up, whether there is any association between regional β-amyloid burden, atrophy on magnetic resonance imaging (MRI) and global cognitive impairment, aphasia or other cognitive and functional impairment in aphasic AD is assessed. METHODS: Forty-four aphasic AD subjects who underwent PiB scanning and volumetric MRI and were determined to be positive for β-amyloid deposition were analyzed. All had completed detailed neurological, neuropsychological and language batteries. Spearman's rank-order correlation was utilized to assess for associations. RESULTS: Greater visuospatial impairment was associated with increased β-amyloid burden in the primary visual cortex (P = 0.001). Although there were many trends for associations between neurocognitive and language deficits and regional β-amyloid burden, there were no strong associations that survived correction for multiple comparisons. However, neurocognitive and language impairment in these subjects strongly correlated with the degree of left lateral temporal and inferior parietal atrophy (P < 0.004). CONCLUSIONS: The findings from this study suggest a close relation between the severity of regional atrophy and cognitive and language impairment, but argue against a strong association between regional β-amyloid burden and such deficits in aphasic AD subjects. Hence, other pathological factors may be driving the previously identified association between global β-amyloid deposition and general cognitive impairment in aphasic AD.
Authors: Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe Journal: Ann Neurol Date: 2011-01 Impact factor: 10.422
Authors: Y Jung; J L Whitwell; J R Duffy; E A Strand; M M Machulda; M L Senjem; V Lowe; C R Jack; K A Josephs Journal: Eur J Neurol Date: 2013-12-16 Impact factor: 6.089
Authors: Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Rong Xia; Jay Mandrekar; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Keith A Josephs Journal: Brain Lang Date: 2013-03-28 Impact factor: 2.381
Authors: K A Josephs; J L Whitwell; J R Duffy; W A Vanvoorst; E A Strand; W T Hu; B F Boeve; N R Graff-Radford; J E Parisi; D S Knopman; D W Dickson; C R Jack; R C Petersen Journal: Neurology Date: 2008-01-01 Impact factor: 9.910
Authors: Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: Jonathan D Rohrer; Matthew J Clarkson; Raivo Kittus; Martin N Rossor; Sebastien Ourselin; Jason D Warren; Nick C Fox Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Alberto Villarejo-Galende; Sara Llamas-Velasco; Adolfo Gómez-Grande; Verónica Puertas-Martín; Israel Contador; Pilar Sarandeses; Marta González-Sánchez; Rocío Trincado; Patrick Pilkington; Sebastián Ruiz-Solis; David A Pérez-Martínez; Alejandro Herrero-San Martín Journal: J Neurol Date: 2016-11-04 Impact factor: 4.849
Authors: Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici Journal: Brain Date: 2016-03-08 Impact factor: 13.501
Authors: Ivan Koychev; Roger N Gunn; Azadeh Firouzian; Jennifer Lawson; Giovanna Zamboni; Basil Ridha; Barbara J Sahakian; James B Rowe; Alan Thomas; Lynn Rochester; Dominic Ffytche; Robert Howard; Henrik Zetterberg; Clare MacKay; Simon Lovestone Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Andrew J Trease; Joseph W George; Nashanthea J Roland; Eliezer Z Lichter; Katy Emanuel; Steven Totusek; Howard S Fox; Kelly L Stauch Journal: Front Mol Neurosci Date: 2022-03-10 Impact factor: 5.639